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The prevalence and management of prescribed 
medication abuse is outlined. The patterns of 
presentation are related to availability and the abuser’s 
profile. Ireland recorded a world first in the abuse of 
Diconal. Methadone is replacing heroin as a problem 
drug among abusers. Early recognition and intervention 
give good treatment outcomes. 
Amphetamines are synthetic 
stimulants first produced in 1887, 
but not used medically until the 
1930’s. During the Second World 
War and the Vietnam War 
amphetamines (Dexedrine) were 
used to increase the performance of 
soldiers. In the 1950’s and 1960’s 
they were widely prescribed as 
slimming tablets and used to treat 
mild depression. The non medical 
use of amphetamines was very 
popular among teenagers during the 
1960’s when large quantities of 
“purple hearts” were taken to stay 
awake at parties. A number of other 
drugs such as methylphenidate 
(Ritalin), diehylpropin hydrochlor. 
(Tenutate Dospan) and fenfluramine 
hydrochlor. (Ponderax) have 
amphetamine like effects; the latter 
two are usually used as sliming 
agents while methylphenidate is 
mainly used in the treatment of 
narcolepsy and the hyperkinetic 
syndrome. 
 
 Tolerance to many of the 
effects of amphetamines develops 
rapidly, with some users taking up 
to 1 gramme per day. When the drug 
is discontinued a user feels 
depressed, fatigued, sleepy and 
extremely hungry. The amphe-
tamine has  _____________________________  
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merely postponed fatigue and 
hunger and depleted the body’s own 
reserves of energy, this feeling is 
called the “crash”. Regular users of 
high doses are liable to develop an 
‘amphetamine psychosis’ which 
resembles schizophrenia with 
thought disorder, hallucinations and 
delusional thinking. These latter 
feelings may lead to hostility, 
aggression and violence as they 
defend themselves against 
imaginary enemies. The psychosis 
usually disappears when drug-
taking stops, but in some people it 
may persist for some considerable 
time. 
 Violence rather than toxicity 
has been the major cause of death 
among amphetamine users. 
However, the hazards of injecting 
and the lack of sleep and food 
debilitates the heavy users, lowers 
resistance to infection, and can lead 
to serious damage of health. 
 Amphetamines were controlled 
in 1970 in an attempt to reduce their 
availability. As a result very few 
patients currently attending the 
Centre admit to the abuse of 
amphetamines. The small number 
that occasionally use amphetamines 
tend to be patients with a drug 
history dating from the late 1960’s 
or early 1970’s. 
 In the 1960’s barbiturates were 
extensively used to treat anxiety and 
insomnia and prescriptions for these 
drugs comprised 20% of all 
prescriptions written. The adverse 
effects of barbiturates include 
drowsiness, loss of co-ordination, 
lethargy, slurred speech and 
confusion. These effects resemble 
alcohol intoxication and 
unpredictable changes in mood, 
similar to those that follow alcohol 
intake, occur ranging from elation 
and euphoria to depression. 
Tolerance develops rapidly and 
death from respiratory depression 
following overdose was once 
common. 
 Following abrupt cessation a 
withdrawal syndrome consisting of 
apprehension, anxiety and confusion 
 
 
 
TABLE 1 
Stimulants: 
Drug Street Name 
1. Amphetamines Speed, Dexies. 
2. Ritalin (methylphenidate) Rits 
3. Anorectics (e.g. Tenuate Dospan) ‘Tomb Stones’ 
 
TABLE 2 
Sedatives: 
Drug Street Name 
1. Barbiturates Barbs 
2. Non-Barbiturates 
(a) Dalmane (flurazepam), Mogadon 
(nitrazepam), Halcion (triazolam) 
(b) Valium (diazepam), Librium 
(chlordiazepoxide), Heminevrin 
(chlormethiazole) Tranks 
3. Antihistamines (cough mixtures): 
Phensedyl (promethazine hydrochloride) 
Actified linctus (triprolidien 
hydrochloride) 
 
TABLE 3 
Typical profile of a minor tranquillizer abuser 
1. An older age group - majority of these patients are 30+ years and are 
women. 
2. Longer history of abuse - often more than 10 years. 
3. Better educational attainment - many will have remained at school until 16 
or 17 years old. 
4. No legal involvement. 
5. history of employment/role of housewife for a number of years. 
6. Good support from family/spouse. 
7. History of alcohol abuse prior to becoming addicted to minor tranquillizers. 
 
TABLE 4 
Opiate & Opiate Analogues: 
Drug Street Name 
1. Diconal (dipipanone hydrochlor) Dyke. 
2. Palfium (dextromoramide) Palf. 
3. Physeptone (methadone) Phy. 
4. Others - Pethidine, Morphine, Omnopon, 
DF118, Fortral, Temgesic, Doloxene Co. 
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is well recognised. Delusions 
hallucinations and convulsions can 
also occur. Likewise dependence 
was common with barbiturates but 
these are now largely replaced as 
anxiolytics and hypnotics by the 
benzodaizepines which have a much 
greater safety margin. The 
undoubted superiority of these drugs 
over barbiturates engendered 
complacency and it is only 
comparatively recently that the 
adverse effects of benzodiazepines 
have been recognised. Chief among 
these is a withdrawal syndrome 
consisting of rebound anxiety on 
cessation of treatment following 
prolonged use. Part of the difficulty 
in recognising this syndrome is that 
it consists largely of the sort of 
symptoms that the drug was initially 
used to treat. Only time can 
distinguish a true withdrawal 
syndrome from re-assertion of the 
anxiety disorder as the withdrawal 
effects can persist for some weeks. 
They appear within 2-3 days of 
abrupt cessation of a short acting 
drug or within a week with a long 
acting drug. Such withdrawal 
symptoms occur whether the drug is 
being used as an anxiolytic or a 
hypnotic. About half those who 
experience a withdrawal syndrome 
also experience perceptual 
disturbances to some degree. These 
may include heightened awareness 
of sensory stimuli, feeling of 
continuous movement, and 
depersonalisation. Infrequently, 
convulsions, delusions or 
hallucinations can occur. In 
summary, the withdrawal is similar 
to that following barbiturate 
withdrawal but markedly less 
severe. Deliberate slow reduction in 
dosage over 1-3 months constitutes 
the best protective measure apart for 
the more sensible measure of 
limiting usage of benzodiazepines to 
intermittent and short term use with 
a frequent review of treatment. 
 The number of patients 
presenting for treatment at the 
Clinic whose primary drug of 
addiction is one of the minor 
 
 
 
 
tranquillizers such as Lorazepam or 
Diazepam has increased greatly over the 
past few years, 
 Figure 1 gives an indication of the 
extent of this trend but the numbers 
given per month of those abusing minor 
tranquillizers reflect 
the total number of patients abusing 
these drugs and not just those who are 
primarily addicted to minor 
tranquillizers. The characteristics of most 
of these patients vary considerably from 
our opiate abusing patient population. 
Table 3 
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 As can be seen from this profile 
many of those abusing tranquillizers 
also have many positive aspects to their 
lives which can act as strong motivating 
factors in rehabilitation e.g. fear of loss 
of a job. While initially these patients 
find the process of detoxification very 
difficult and experience much anxiety 
and even depression afterwards, if they 
can be helped through this difficult 
phase eventual rehabilitation may be 
successful. 
Cough remedies, decongestants and 
antihistamines 
Doctors will be familiar with the 
potential for abuse of these 
preparations. Cough mixtures frequently 
contain a miscellany of ingredients with 
abuse potential including a morphine-
like cough suppressant, a 
sympathomimetic and an antihistamine. 
The indirectly acting sympathomimetics 
used as decongestants or 
bronchodilators have abuse potential 
related to that of the amphetamines in 
that they are generally structurally 
similar to amphetamines and exhibit 
some central stimulant activity. 
 Many antihistamines have 
pronounced central depressant activity 
especially in combination with alcohol. 
Experience suggests that any medicines 
with central depressant activity have 
abuse potential and it is clear that the 
most potent sedative antihistamine 
mixtures are sought by abusers. 
 In the Centre between 5-25 patients 
are seen per month who are abusing 
cough mixtures. Many tend to be in the 
younger age group i.e. under 20 years of 
age. 
 Medical use of the more potent 
opiates such as morphine diamorphine, 
methadone, pethidine, and dipipanone is 
reserved for the treatment of intractable 
severe pain and are subject to such close 
medical supervision that the risk of 
dependence can be predicted and 
controlled. Less stringent observation 
frequently applies when medium 
potency analgesics are used 
 
 
 
 
 
 
 
 
 
 
PRACTICAL POINTS 
• Violence, rather than toxicity, 
has been the major cause of death 
among amphetamine users. 
• In the 1980’s barbiturates 
were extensively used and 
comprised about 20% of all 
prescriptions written. 
• The number of patients whose 
primary drug of addiction is one of 
the minor tranquillizers has 
increased greatly over the past few 
years. 
• Cough mixtures frequently 
contain a miscellany of ingredients 
with abuse potential. 
• The majority of patients, 
about 80%, attending the Drug 
Treatment Centre are addicted to 
Heroin as their drug of first 
choice. 
• Ireland was the first country 
in the world o report cases of 
Diconal abuse 
for painful conditions in which aspirin, 
paracetamol or ibuprofen do not provide 
analgesia are inappropriate. 
 Prolonged regular use constitutes 
the greatest risk factor inducing 
dependence with all of these drugs. 
Under these conditions tolerance also 
develops. Greatest risk of moderate 
opiate dependence occurs with 
prolonged use of Fortral (pentazocine) 
and likewise mild to moderate 
dependence can occur with Doloxene 
Codeine and DF118 (dihydrocodeine 
tartrate). 
 Overdose with these drugs 
produces respiratory depression and 
many of the other undesirable effects of 
morphine. In therapeutic doses they 
may impair motor performance making 
driving or operating machinery 
hazardous. These 
 
 
 
 
 
 
 
 
 
 
 
 
 
adverse central depressant actions are 
potentiated by alcohol. 
 The majority of patients, about 
80% attending the Drug Treatment 
Centre, are addicted to Heroin as their 
drug of first choice (Figure 2). 
 However, most patients will 
substitute other opiates when Heroin is 
not available e.g. Dipipanone, 
Dextromoramide or Methadone. Ireland 
was the first country in the world to 
report cases of Diconal abuse. More 
recently, the Centre has noted a large 
increase in the number of patients 
abusing methadone, as illustrated in 
Figure 3. 
 In 1982, 14 patients were reported 
as abusing Methadone and this figure 
rose 97 in 1985. In 1987, 298 patients 
were identified as abusing Methadone - 
a twenty fold increase on the 1982 
figure. The careful control and 
monitoring of methadone either in 
maintenance of detoxification is the 
cornerstone of treatment at the Unit. 
The increasing availability of 
Methadone on the street greatly 
undermines efforts to control out-patient 
detoxification programmes. As a result 
all patients abusing methadone can only 
be offered in-patient detoxification. This 
has created yet a further demand on the 
limited number of beds available in the 
in-patient unit at Beaumont Hospital. As 
most of the Heroin available in Dublin 
is only 10-15% pure, detoxification may 
only take about two weeks, whereas a 
patient using a substantial quantity of 
Methadone clearly needs a much higher 
initial dose and a longer period of 
withdrawal. 
Conclusion 
It is hoped that this brief outline of the 
abuse of prescribed medication will 
heighten awareness of the abuse 
potential of certain drugs. Further, that 
patients in the earlier stages of 
dependency will be recognised and 
referred for treatment. Early 
intervention has been shown to greatly 
facilitate a positive treatment outcome. 
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